While Stericycle's earnings per share met analyst expectations and showed growth from the previous year, the miss on sales estimates and the year-over-year decrease in sales could temper investor enthusiasm. The EPS growth is a positive sign, indicating operational efficiency or cost management success. However, the sales miss suggests potential challenges in revenue growth, which could lead to cautious optimism among investors. The overall impact on the stock price is likely neutral in the short term, as the positive earnings report is balanced by the less favorable sales figures.